Dr Amanda Marie Dick, MD | |
Schneck Professional Building, 411 West Tipton Street, Seymour, IN 47274 | |
(812) 519-2388 | |
(812) 519-3182 |
Full Name | Dr Amanda Marie Dick |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 19 Years |
Location | Schneck Professional Building, Seymour, Indiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417037938 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 01068465A (Indiana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Schneck Medical Center | Seymour, IN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Jackson County Schneck Memorial Hospital | 8224004585 | 108 |
News Archive
Each year, an estimated 700,000 persons experience adverse drug events that lead to emergency department visits, according to a study in the October 18 issue of JAMA: The Journal of the American Medical Association.
Spending on low-value health care among fee-for-service Medicare recipients dropped only marginally from 2014 to 2018, despite both a national campaign to better educate clinicians and increasing use of payment revisions that discourage wasteful care, according to a new RAND Corporation study.
Human eyes naturally contain yellow pigment in the macula, a spot near the center of the retina responsible for high-resolution vision. Those with more yellow in their macula may have an advantage when it comes to filtering out atmospheric particles that obscure one's vision, commonly known as haze.
Adding cilostazol - an antiplatelet medication used to treat leg pain - tended to prevent re-blockage of carotid artery stents within two years, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2020. The conference, Feb. 19-21 in Los Angeles, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has applied for the voluntary delisting of OXiGENE common shares from the Stockholm Stock Exchange (SSE). The company will continue to be listed on the NASDAQ Global Markets exchange.
› Verified 3 days ago
Entity Name | Jackson County Schneck Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629143037 PECOS PAC ID: 8224004585 Enrollment ID: O20041029000584 |
News Archive
Each year, an estimated 700,000 persons experience adverse drug events that lead to emergency department visits, according to a study in the October 18 issue of JAMA: The Journal of the American Medical Association.
Spending on low-value health care among fee-for-service Medicare recipients dropped only marginally from 2014 to 2018, despite both a national campaign to better educate clinicians and increasing use of payment revisions that discourage wasteful care, according to a new RAND Corporation study.
Human eyes naturally contain yellow pigment in the macula, a spot near the center of the retina responsible for high-resolution vision. Those with more yellow in their macula may have an advantage when it comes to filtering out atmospheric particles that obscure one's vision, commonly known as haze.
Adding cilostazol - an antiplatelet medication used to treat leg pain - tended to prevent re-blockage of carotid artery stents within two years, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2020. The conference, Feb. 19-21 in Los Angeles, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has applied for the voluntary delisting of OXiGENE common shares from the Stockholm Stock Exchange (SSE). The company will continue to be listed on the NASDAQ Global Markets exchange.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Amanda Marie Dick, MD Schneck Professional Building, 411 West Tipton Street, Seymour, IN 47274 Ph: (812) 519-2388 | Dr Amanda Marie Dick, MD Schneck Professional Building, 411 West Tipton Street, Seymour, IN 47274 Ph: (812) 519-2388 |
News Archive
Each year, an estimated 700,000 persons experience adverse drug events that lead to emergency department visits, according to a study in the October 18 issue of JAMA: The Journal of the American Medical Association.
Spending on low-value health care among fee-for-service Medicare recipients dropped only marginally from 2014 to 2018, despite both a national campaign to better educate clinicians and increasing use of payment revisions that discourage wasteful care, according to a new RAND Corporation study.
Human eyes naturally contain yellow pigment in the macula, a spot near the center of the retina responsible for high-resolution vision. Those with more yellow in their macula may have an advantage when it comes to filtering out atmospheric particles that obscure one's vision, commonly known as haze.
Adding cilostazol - an antiplatelet medication used to treat leg pain - tended to prevent re-blockage of carotid artery stents within two years, according to late-breaking science presented today at the American Stroke Association's International Stroke Conference 2020. The conference, Feb. 19-21 in Los Angeles, is a world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has applied for the voluntary delisting of OXiGENE common shares from the Stockholm Stock Exchange (SSE). The company will continue to be listed on the NASDAQ Global Markets exchange.
› Verified 3 days ago
Richard Allen Wiethoff, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 225 S Pine St Suite 310, Seymour, IN 47274 Phone: 812-522-2177 Fax: 812-522-4069 | |
Dr. Gerald Brandon Millick, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Schneck Professional Building, 411 West Tipton Street, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 | |
Dr. Jeffrey E Schulz, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: Schneck Medical Center, 411 West Tipton Street, Seymour, IN 47274 Phone: 812-524-8346 Fax: 812-524-4231 | |
Dr. Susan M. Maurer, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 | |
Dr. Joyce Renee Iwema, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Schneck Surgical Associates, 411 West Tipton Street, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 | |
Dr. Antonio D. Spates, Surgery Medicare: Medicare Enrolled Practice Location: 411 W Tipton St, Seymour, IN 47274 Phone: 812-519-2388 Fax: 812-519-3182 |